CAPA serves as the engine of a high-performance Pharmaceutical Quality System (PQS). It shifts quality management from reactive "firefighting" to a results-oriented strategy that optimizes processes across manufacturing and the global supply chain. Authorities such as the FDA, WHO, EMA, and CDSCO require a robust CAPA system. During GMP inspections, your CAPA records tell the story of your quality culture and your commitment to operational excellence.

This June 2026 notification signals a maturing pharmacovigilance framework. For stakeholders from large-scale manufacturers and CMOs to frontline healthcare providers, the message is clear: scientific justification is the only path to market survival. This article breaks down the ban and explores the strategic shifts necessary for industry compliance.

The shift towards preventive healthcare marks a new era where consumers are not just seeking convenience but demanding certainty. The nutraceutical industry is at a critical juncture, moving from a market driven by aggressive marketing to one anchored in scientific rigor and regulatory compliance. The days of broad, unsubstantiated claims are over. Long-term consumer confidence is no longer built on flash-in-the-pan trends but on the immutable foundation of proven quality, sa

In the fast-evolving world of pharmaceutical manufacturing, the operation of evaporation is far more than simple solvent removal. It is a mission-critical, scientifically engineered transformation that directly determines product quality, therapeutic potency, and regulatory success. Achieving precise concentration through controlled evaporation is a cornerstone of product stability, bioavailability, shelf life, and successful downstream processing.

Navigate the distinct roles of CDSCO and State FDA to ensure faster approvals, full compliance, and successful market entry. 1....